← Back to Search

Behavioural Intervention

Transcranial Magnetic Stimulation for Schizophrenia

N/A
Recruiting
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
DSM-V diagnosis of schizophrenia spectrum disorders
Male or female subjects 18 to 40 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of 2nd week and 4th week
Awards & highlights

Study Summary

This trial is investigating the effects of 4-week rTMS treatment on brain and cognitive functions in patients with schizophrenia. Subjects will be randomized to receive either active or sham rTMS. fMRI scans, clinical assessments, and cognitive tests will be performed at baseline, end of the 2nd week, and end of the 4th week.

Who is the study for?
This trial is for individuals aged 18-40 with a diagnosis of schizophrenia spectrum disorders. It's not suitable for those with cerebellar disorders, recent TMS or ECT treatments, MRI contraindications, active medical conditions affecting cognition, substance abuse within six months, seizure history, or other major psychiatric or neurodegenerative diagnoses.Check my eligibility
What is being tested?
The study tests the impact of Transcranial Magnetic Stimulation (rTMS) on brain and cognitive functions in schizophrenia patients over four weeks. Participants will either receive real rTMS plus standard care or sham rTMS (a placebo-like procedure) plus standard care to compare effects.See study design
What are the potential side effects?
Possible side effects from rTMS may include discomfort at the stimulation site, headache, lightheadedness, seizures (very rare), and hearing changes if ear protection isn't used during treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a schizophrenia spectrum disorder.
Select...
I am between 18 and 40 years old.
Select...
I understand and can agree to the study's procedures and risks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of 2nd week and 4th week
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of 2nd week and 4th week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cerebellar function
Secondary outcome measures
Cognitive function
Other outcome measures
Cerebellum-cognition associations

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: TMSExperimental Treatment1 Intervention
Group II: ShamPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Magnetic Stimulation
2017
Completed Phase 4
~730

Find a Location

Who is running the clinical trial?

Northwell HealthLead Sponsor
460 Previous Clinical Trials
470,983 Total Patients Enrolled
28 Trials studying Schizophrenia
4,384 Patients Enrolled for Schizophrenia

Media Library

Transcranial Magnetic Stimulation (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05389787 — N/A
Schizophrenia Clinical Trial 2023: Transcranial Magnetic Stimulation Highlights & Side Effects. Trial Name: NCT05389787 — N/A
Transcranial Magnetic Stimulation (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05389787 — N/A
Schizophrenia Research Study Groups: TMS, Sham

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the age restriction for this clinical trial encompass individuals who are over 25?

"The requirements for those wanting to join this clinical trial are between 18 and 40 years of age. For patients younger than 18, there are 49 studies available whereas for adults over 65, 173 studies can be found."

Answered by AI

What is the upper limit to the number of volunteers engaged in this experiment?

"Affirmative. Clinicaltrials.gov demonstrates that this clinical trial is currently looking for volunteers, having been first posted on August 18th 2022 and edited most recently the same day. The project needs to find 60 participants from 1 research centre."

Answered by AI

Would I qualify to partake in this clinical exploration?

"This medical trial is recruiting 60 individuals with a DSM-V diagnosis of schizophrenia, who are between 18 and 40 years old. Furthermore they must meet the criteria of being legally competent to give informed consent as well as their gender identity."

Answered by AI

Are participants being accepted at this stage of the clinical trial?

"Correct. Clinicaltrials.gov has data affirming that this medical trial, which was originally posted on August 18th 2022, is presently enrolling patients. 60 participants are needed from a single center to complete the study's goals."

Answered by AI

Who else is applying?

What site did they apply to?
Zucker Hillside Hospital
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I tried a lot of medication and it is not working. I want to be better and be an active member of society.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study
Hengyi Cao 2022. "Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05389787.
All > Schizophrenia
~27 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top